OHR Pharmaceutical
Company Description
OHR Pharmaceutical develops products for the treatment of cancer cachexia and wet age-related macular degeneration.
OHR Pharmaceutical, Inc., a development stage biotechnology company, focuses on the development of products for the treatment of cancer cachexia (multi-symptom wasting disorder) and wet- age-related macular degeneration.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
489 5th Avenue, 28th FloorNew York, NYUnited States -
CEO:
- Irach Taraporewala
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits